AstraZeneca’s Voydeya Scores FDA Approval, Adding to Company’s Multi-Billion Dollar PNH Franchise
XTalks
APRIL 3, 2024
The RBCs in circulation are marked by proteins in the complement system for removal by the spleen and liver. Voydeya’s FDA approval was based on positive results from the pivotal ALPHA Phase III trial. And Alexion had acquired danicopan through its 2019 purchase of Achillion Pharmaceuticals for almost $1 billion.
Let's personalize your content